Schriftgut
Ibusal-Tabletten 200 und 400 mg (Orion Corporation Ltd./Orion Pharmaceutica): Bd. 2
Enthält nur:
Bescheide über die staatliche Zulassung
- Reference number
-
Bundesarchiv, BArch DQ 116/289
- Former reference number
-
Aktenzeichen: 00/19/78, 79
- Language of the material
-
deutsch
- Context
-
Institut für Arzneimittelwesen (IFAR) der DDR >> DQ 116 Institut für Arzneimittelwesen (IFAR) der DDR >> Zulassung von im Ausland hergestellten Arzneimitteln in der DDR (Importe) >> Republik Finnland (00/19) >> Ibusal-Tabletten 200 und 400 mg (Orion Corporation Ltd./Orion Pharmaceutica)
- Holding
-
BArch DQ 116 Institut für Arzneimittelwesen (IFAR) der DDR
- Provenance
-
Institut für Arzneimittelwesen der DDR (IFAR), 1974-1990
- Date of creation
-
3. Sept. 1990
- Other object pages
- Last update
-
30.01.2024, 2:22 PM CET
Data provider
This object is provided by:
Bundesarchiv. If you have any questions about the object, please contact the data provider.
Bundesarchiv. If you have any questions about the object, please contact the data provider.
Object type
- Schriftgut
Associated
- Institut für Arzneimittelwesen der DDR (IFAR), 1974-1990
Time of origin
- 3. Sept. 1990
Other Objects (12)
Metypred (Orion Corporation Limited/Orion Pharmaceutica): 4 mg Tabletten
Metypred (Orion Corporation Limited/Orion Pharmaceutica): Tabletten 16 mg
Hismanal-Tabletten 10 mg (Orion Corporation Ltd./Orion Pharmaceutica): Bd. 2
Hismanal-Tabletten 10 mg (Orion Corporation Ltd./Orion Pharmaceutica): Bd. 1
Doximycin-Tabletten 100 mg (Orion Pharmaceutica)
Kefexin (Orion Pharmaceutica): Tabletten 500 mg
Verpamil (Orion-yhtymä Oy/Orion Pharmaceutica): Tabletten 40 mg
Metypred (Orion Corporation Limited/Orion Pharmaceutica): Ampullen und Tabletten
Ibusal-Tabletten 200 und 400 mg (Orion Corporation Ltd./Orion Pharmaceutica): Bd. 1
Metypred (Orion Corporation Limited/Orion Pharmaceutica): Ampullen 250 mg intravenös
Verpamil (Orion-yhtymä Oy/Orion Pharmaceutica): Tabletten 40 und 80 mg
Metypred (Orion Corporation Limited/Orion Pharmaceutica): 4 mg Tabletten, 40 mg/ml Depotinjektion-Ampullen und 125 mg Ampullen
Metypred (Orion Corporation Limited/Orion Pharmaceutica): 4 mg Tabletten
Metypred (Orion Corporation Limited/Orion Pharmaceutica): Tabletten 16 mg
Hismanal-Tabletten 10 mg (Orion Corporation Ltd./Orion Pharmaceutica): Bd. 2
Hismanal-Tabletten 10 mg (Orion Corporation Ltd./Orion Pharmaceutica): Bd. 1
Doximycin-Tabletten 100 mg (Orion Pharmaceutica)
Kefexin (Orion Pharmaceutica): Tabletten 500 mg
Verpamil (Orion-yhtymä Oy/Orion Pharmaceutica): Tabletten 40 mg
Metypred (Orion Corporation Limited/Orion Pharmaceutica): Ampullen und Tabletten
Ibusal-Tabletten 200 und 400 mg (Orion Corporation Ltd./Orion Pharmaceutica): Bd. 1
Metypred (Orion Corporation Limited/Orion Pharmaceutica): Ampullen 250 mg intravenös
Verpamil (Orion-yhtymä Oy/Orion Pharmaceutica): Tabletten 40 und 80 mg
Metypred (Orion Corporation Limited/Orion Pharmaceutica): 4 mg Tabletten, 40 mg/ml Depotinjektion-Ampullen und 125 mg Ampullen
Metypred (Orion Corporation Limited/Orion Pharmaceutica): 4 mg Tabletten
Metypred (Orion Corporation Limited/Orion Pharmaceutica): Tabletten 16 mg
Hismanal-Tabletten 10 mg (Orion Corporation Ltd./Orion Pharmaceutica): Bd. 2
Hismanal-Tabletten 10 mg (Orion Corporation Ltd./Orion Pharmaceutica): Bd. 1
Doximycin-Tabletten 100 mg (Orion Pharmaceutica)
Kefexin (Orion Pharmaceutica): Tabletten 500 mg
Verpamil (Orion-yhtymä Oy/Orion Pharmaceutica): Tabletten 40 mg
Metypred (Orion Corporation Limited/Orion Pharmaceutica): Ampullen und Tabletten
Ibusal-Tabletten 200 und 400 mg (Orion Corporation Ltd./Orion Pharmaceutica): Bd. 1
Metypred (Orion Corporation Limited/Orion Pharmaceutica): Ampullen 250 mg intravenös
Verpamil (Orion-yhtymä Oy/Orion Pharmaceutica): Tabletten 40 und 80 mg